>北美真皮填充剂市场，按产品类型（可生物降解真皮填充剂、不可生物降解真皮填充剂）、材料类型（天然真皮填充剂、合成真皮填充剂）、应用（拉皮、隆鼻、重建手术、面部线条矫正、唇部增强、皮肤松弛、面颊凹陷、皮肤平滑、牙科、美学修复、丰唇、疤痕治疗、下巴增大、脂肪萎缩治疗、耳垂年轻化等）、药品类型（品牌、通用）、最终用户（皮肤科诊所、门诊手术中心、医院、学术研究机构等）、分销渠道（直接招标、药店、零售药店、网上药店等）划分 - 行业趋势和预测到 2029 年。
北美皮肤填充剂市场分析与洞察
真皮填充剂是一种凝胶状物质，注射到皮肤下可恢复失去的体积，通常可消除皱纹和平滑细纹或增强面部轮廓。近年来，真皮填充剂的使用量迅速增长，因为各种产品都可用于增强美观和恢复活力，而这些效果以前只能通过手术来实现。这些产品已成为非常流行的面部恢复方法。作为微创产品，真皮填充剂在美容体积替代疗法中可立即见效。这些设备可增加面部体积，改善和提高皮肤质量。各种方法（例如注射）都可用于增大。出于美容目的，这些填充剂可使嘴唇更丰满、更丰满。有许多类型的真皮填充剂可注射到嘴唇和嘴周围，根据所用产品的类型，可暂时或永久保持嘴唇的体积。一些市场参与者参与了新产品和创新产品，他们的产品正在筹备中。过去几年，为了促进真皮填充剂市场的增长，市场参与者开发了新的创新真皮填充剂产品，并不断增强其产品组合。许多市场参与者都参与了真皮填充剂的生产，并通过创新为市场增长铺平了道路。
Data Bridge Market Research 分析，真皮填充剂市场预计到 2029 年将达到 57.1457 亿美元的价值，在 2022-2029 年预测期内的复合年增长率为 11.4%。
|
报告指标 |
细节 |
|
预测期 |
2022 至 2029 年 |
|
基准年 |
2021 |
|
历史性的一年 |
2020 (可定制至 2019-2014) |
|
定量单位 |
收入（百万美元）、销量（单位）、定价（美元） |
|
涵盖的领域 |
按产品类型（可生物降解的真皮填充剂、不可生物降解的真皮填充剂）、材料类型（天然真皮填充剂、合成真皮填充剂）、应用（拉皮、隆鼻、重建手术、面部线条矫正、唇部增强、皮肤松弛、面颊凹陷、皮肤平滑、牙科、美容修复、丰唇、疤痕治疗、下巴增大、脂肪萎缩治疗、耳垂年轻化等）、药品类型（品牌、通用）、最终用户（皮肤科诊所、门诊手术中心、医院、学术研究机构等）、分销渠道（直接招标、药店、零售药店、网上药店等） |
|
覆盖国家 |
北美的美国、加拿大、墨西哥 |
|
涵盖的市场参与者 |
Allergan（Abbvie 公司旗下的子公司）、Prollenium Medical Technologies、Suneva Medical、Revance Therapeutics, Inc.、FillMed Laboratories、Anika Therapeutics, Inc、Ipsen Pharma、BIOXIS Pharmaceuticals、Zimmer Aesthetic、浙江景嘉医疗科技有限公司、Medytox、Contura International ltd.、上海瑞阳医疗科技有限公司、Humedix（HUONS GLOBAL 旗下的子公司）、Galderma Laboratories, LP、Merz North America, Inc.（Merz Pharma 旗下的子公司）、Croma-Pharma GmbH、Sinclair Pharma（华东医药股份有限公司旗下的子公司）、Teoxane、BioPlus Co., Ltd.、Amalian、Givaudan、Mesoestetic、Sosum Global、DSM、IBSA Nordic ApS 等。 |
市场定义
真皮填充剂是注射到皮肤中以增加丰满度和体积的物质。真皮填充剂中使用的物质包括羟基磷灰石钙（骨骼中发现的矿物质类化合物）、透明质酸、聚烷基酰亚胺、聚乳酸、聚甲基丙烯酸甲酯微球 (PMMA)。真皮填充剂可根据多种标准进行分类，包括深层真皮、植入深度（浅层、中层和上层以及皮下层）；矫正的持久性（暂时性和永久性）；过敏性、药剂的成分（同种异体移植、半/全合成、异种移植或自体）；以及刺激行为（内源性组织增殖的生理过程）与替代填充剂（空间替代效应）。
HA 和胶原蛋白等临时真皮填充剂可生物降解，可持续 4 至 9 个月。预期的副作用和不满意也是短暂的。因此，临时填充剂始终被用作第一线治疗方法，以节省长期填充剂以供患者将来就诊。
永久性填充剂主要用于改变皮肤深层皱纹和沟纹，这些皱纹和沟纹超出了正常的面部皱纹。它们被认为是面部年轻化的绝佳选择，尤其是对于 HIV 脂肪营养不良患者。聚甲基丙烯酸甲酯 (PMMA) 主要用于安全、有效和持久的效果。
皮肤填充剂市场动态
本节旨在了解市场驱动因素、优势、机遇、限制和挑战。以下内容将详细讨论所有这些内容：
驱动程序
- 微创手术日益普及
与传统的美容和整容手术技术（包括激光和其他基于能量的设备）相比，微创手术的使用已经发生了变化。对于手术或非手术程序的使用，已经开发了专门设计的用于微创手术的仪器。这些抗衰老设备有助于通过恢复和收紧皮肤来减少皮肤老化的视觉效果，从而使皮肤看起来更年轻。
微创手术是在望远镜和专门配备的手术器械的帮助下进行的手术。它针对面部不规则，包括皱纹和细纹，减少体积和轮廓以及多余脂肪。这些手术基本上没有严重不良事件的风险，因为手术不会造成切口或切口很小，恢复时间较短，这增加了对微创手术的需求。用于紧致皮肤、减少皱纹、面部轮廓和皮肤年轻化的微创能量治疗在世界范围内需求量很大。推动这些手术需求的其他原因是老龄化人口增加和医疗设施需求增加，这可以进一步减轻医疗设施的负担。
随着技术进步和通信的不断进步，人们越来越了解在医疗保健领域表现良好的美容设备和程序，这将对即将到来的时代采用微创手术产生积极影响。因此，微创手术的日益普及预计将推动真皮填充剂市场的增长。
- 老年人口不断增加
老年人口不断增加，寿命越来越长，据报道，皮肤老化问题日益严重。世界人口老龄化速度呈指数级增长，而欧洲国家具有某些共同的文化、社会和经济特征，有着类似的愿望。随着人们开始衰老，外表变得越来越年轻，这最终引起了人们对美容手术的兴趣。
中东国家老年人口比例的不断提高及其医疗保健状况的改善为患者带来了更好的治疗结果服务。
机会
- 增加对美学研究的资助活动
整形手术、去除多余毛发、紧致肌肤、抗衰老、去除多余脂肪、塑身和其他一些美容手术都是通过微创手术进行的，这些手术是在医疗美容设备下进行的，用于改善外观、美化和改善身体的其他部位。各种基金会和政府组织都在美学研究方面投入了大量资金。
- 新型真皮填充剂的进展
真皮填充剂是凝胶状物质，注射到皮下可恢复流失的体积、软化皱纹和抚平细纹。它也用于改善面部轮廓；每年有超过 100 万人选择这种流行的面部改造疗法来恢复皱纹和面部线条的外观。真皮填充剂是一种有效的治疗方法，可让您看起来更年轻，无需恢复期或手术。真皮填充剂药物注射到皮肤中，有助于填充面部皱纹。有不同类型的真皮填充剂药物可供选择，最常见的类型是羟基磷灰石钙、透明质酸、聚烷基酰亚胺、聚乳酸等。真皮填充剂品牌的进步将有助于促进市场需求。
限制/挑战
- 美容手术费用高昂
成本始终是选择性手术的一个考虑因素。真皮填充剂的成本取决于填充剂的类型和治疗中使用的量。此外，治疗费用取决于进行真皮填充剂治疗的人员的资质和专业知识。真皮填充剂的美容治疗是一种安全的门诊手术，是一种非常流行的恢复体积损失和治疗某些衰老迹象的治疗方法，但手术的高成本预计将阻碍市场的需求
- 缺乏熟练的专业人员
美容治疗程序有多种类型，包括基于激光的技术、基于能量的技术以及强脉冲光等。所有这些技术都需要合格的人际交往技巧才能进行有效的治疗。
此外，该领域的技术快速进步也导致熟练专业人员的缺乏。熟练专业人员的缺乏对设备操作和手术程序的执行构成重大挑战。
最新动态
- 2022 年 4 月，Sinclair Pharma 宣布该公司已获得 Perfectha Lidocaine 在皱纹矫正、面部轮廓和体积恢复治疗方面的欧洲 CE 标志。此 CE 认证使 Perfectha Lidocaine 在英国和所有主要欧洲市场上市。
皮肤填充剂市场细分
真皮填充剂市场根据产品类型、材料类型、应用、药物类型、最终用户和分销渠道进行细分。细分市场之间的增长有助于您分析利基增长领域和进入市场的策略，并确定您的核心应用领域和目标市场的差异。
按产品类型
- 可生物降解的真皮填充剂
- 不可生物降解的皮肤填充剂
根据产品类型，真皮填充剂市场分为可生物降解的真皮填充剂和不可生物降解的真皮填充剂。
按材料类型
- 天然皮肤填充剂
- 合成皮肤填充剂
根据材料类型，市场分为天然真皮填充剂和合成真皮填充剂。
按应用
- 面部拉皮
- 鼻整形
- 重建手术
- 面部线条矫正
- 丰唇
- 皮肤松弛
- 面颊凹陷
- 皮肤光滑
- 牙科
- 美容修复
- 唇梅
- 疤痕治疗
- 下巴整形
- 脂肪萎缩治疗
- 耳垂复原
- 其他的
根据应用，市场细分为面部提升、鼻整形、重建手术、面部线条矫正、唇部增强、皮肤松弛、脸颊凹陷、皮肤平滑、牙科、美容修复、疤痕治疗、下巴增大、脂肪萎缩治疗、耳垂年轻化等。
按药物类型
- 品牌
- 通用的
根据药品类型，市场分为品牌药品和仿制药。
按最终用户
- 皮肤科诊所
- 医院
- 门诊手术中心
- 学术研究机构
- 其他的
根据最终用户，市场分为皮肤病诊所、门诊手术中心、医院、学术研究机构和其他。
按分销渠道
- 直接招标
- 药店
- 零售药店
- 网上药店
- 其他的
根据分销渠道，市场分为直接招标、药店、零售药店、网上药店和其他。
真皮填充剂市场区域分析/见解
对真皮填充剂市场进行了分析，并按国家、产品类型、材料类型、应用、药物类型、最终用户和分销渠道提供了市场规模洞察和趋势。
真皮填充剂市场报告涵盖的国家包括北美的美国、加拿大和墨西哥。
由于美国在皮肤治疗中微创手术的使用呈指数级增长，预计美国将占据市场主导地位。
报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场监管变化。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测各个国家市场情景的一些指标。此外，在提供国家数据的预测分析时，还考虑了品牌的存在和可用性以及由于来自本地和国内品牌的大量或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。
竞争格局和真皮填充剂市场份额分析
真皮填充剂市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对真皮填充剂市场的关注有关。
市场上的一些主要参与者包括 Allergan（Abbvie 公司旗下的子公司）、Prollenium Medical Technologies、Suneva Medical、Revance Therapeutics 公司、FillMed Laboratories、Anika Therapeutics 公司、Ipsen Pharma、BIOXIS Pharmaceuticals、Zimmer Aesthetic、浙江景嘉医疗科技有限公司、Medytox、Contura International ltd.、上海瑞阳医疗科技有限公司、Humedix（HUONS GLOBAL 旗下的子公司）、Galderma Laboratories 公司、LP、Merz North America 公司（Merz Pharma 旗下的子公司）、Croma-Pharma GmbH、Sinclair Pharma（华东医药股份有限公司旗下的子公司）、Teoxane、BioPlus 公司、Amalian、Givaudan、Mesoestetic、Sosum Global、DSM、IBSA Nordic ApS 等。
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
目录
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DERMAL FILLERS MARKET
1.4 LIMITATION
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCTS LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES
4.2 PESTEL ANALYSIS
4.3 EPIDEMIOLOGY PROCEDURES PER COUNTRY
5 REGULATIONS OF NORTH AMERICA DERMAL FILLERS MARKET
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISING PREVALENCE OF MINIMALLY INVASIVE PROCEDURES
6.1.2 INCREASING GERIATRIC POPULATION
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN DERMAL FILLERS
6.1.4 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.2 RESTRAINTS
6.2.1 HIGH COST OF AESTHETIC PROCEDURES
6.2.2 ESCALATING PRODUCT RECALL
6.2.3 FDA GUIDELINES FOR ADVANCED DERMAL FILLER INJECTORS
6.3 OPPORTUNITIES
6.3.1 INCREASING HEALTHCARE EXPENDITURE
6.3.2 INCREASING FUNDING ACTIVITIES FOR AESTHETIC RESEARCH
6.3.3 ADVANCEMENT IN THE NEW DERMAL FILLERS
6.3.4 INCREASING COMPENSATION AND ACCIDENTAL CLAIMS FOR DERMAL FILLER
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS
6.4.2 AVAILABILITY OF ALTERNATIVES
7 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE
7.1 OVERVIEW
7.2 BIODEGRADABLE DERMAL FILLERS
7.2.1 TEMPORARY BIODEGRADABLE
7.2.2 SEMI-PERMANENT BIODEGRADABLE
7.3 NON-BIODEGRADABLE DERMAL FILLERS
8 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE
8.1 OVERVIEW
8.2 NATURAL DERMAL FILLERS
8.2.1 HYALURONIC ACID
8.2.1.1 BY TYPE
8.2.1.1.1 MONOPHASIC FILLERS
8.2.1.2 BY TYPE
8.2.1.2.1 MONODENSIFIED
8.2.1.2.2 POLYDENSIFIED
8.2.1.2.3 BIPHASIC FILLERS
8.2.1.3 BY MATERIAL TYPE
8.2.1.3.1 SINGLE-PHASE
8.2.1.3.2 DUPLEX-PHASE
8.2.1.4 BY APPLICATION
8.2.1.4.1 FACE LIFT
8.2.1.4.2 RHINOPLASTY
8.2.1.4.3 RECONSTRUCTIVE SURGERY
8.2.1.4.4 FACIAL LINE CORRECTION
8.2.1.4.5 LIP ENHANCEMENT
8.2.1.4.6 SAGGING SKIN
8.2.1.4.7 CHEEK DEPRESSION
8.2.1.4.8 SKIN SMOOTHING
8.2.1.4.9 DENTISTRY
8.2.1.4.10 AESTHETIC RESTORATION
8.2.1.4.11 SCAR TREATMENT
8.2.1.4.12 CHIN AUGMENTATION
8.2.1.4.13 LIPOATROPHY TREATMENT
8.2.1.4.14 EARLOBE REJUVENATION
8.2.1.4.15 OTHERS
8.2.2 FAT
8.2.2.1 BY APPLICATION
8.2.2.1.1 FACE LIFT
8.2.2.1.2 RHINOPLASTY
8.2.2.1.3 RECONSTRUCTIVE SURGERY
8.2.2.1.4 FACIAL LINE CORRECTION
8.2.2.1.5 LIP ENHANCEMENT
8.2.2.1.6 SAGGING SKIN
8.2.2.1.7 CHEEK DEPRESSION
8.2.2.1.8 SKIN SMOOTHING
8.2.2.1.9 DENTISTRY
8.2.2.1.10 AESTHETIC RESTORATION
8.2.2.1.11 SCAR TREATMENT
8.2.2.1.12 CHIN AUGMENTATION
8.2.2.1.13 LIPOATROPHY TREATMENT
8.2.2.1.14 EARLOBE REJUVENATION
8.2.2.1.15 OTHERS
8.2.3 COLLAGEN
8.2.3.1 BY APPLICATION
8.2.3.1.1 FACE LIFT
8.2.3.1.2 RHINOPLASTY
8.2.3.1.3 RECONSTRUCTIVE SURGERY
8.2.3.1.4 FACIAL LINE CORRECTION
8.2.3.1.5 LIP ENHANCEMENT
8.2.3.1.6 SAGGING SKIN
8.2.3.1.7 CHEEK DEPRESSION
8.2.3.1.8 SKIN SMOOTHING
8.2.3.1.9 DENTISTRY
8.2.3.1.10 AESTHETIC RESTORATION
8.2.3.1.11 SCAR TREATMENT
8.2.3.1.12 CHIN AUGMENTATION
8.2.3.1.13 LIPOATROPHY TREATMENT
8.2.3.1.14 EARLOBE REJUVENATION
8.2.3.1.15 OTHERS
8.2.4 OTHERS
8.3 SYNTHETIC DERMAL FILLERS
8.3.1 POLY-L-LACTIC ACID
8.3.1.1 BY APPLICATION
8.3.1.1.1 FACE LIFT
8.3.1.1.2 RHINOPLASTY
8.3.1.1.3 RECONSTRUCTIVE SURGERY
8.3.1.1.4 FACIAL LINE CORRECTION
8.3.1.1.5 LIP ENHANCEMENT
8.3.1.1.6 SAGGING SKIN
8.3.1.1.7 CHEEK DEPRESSION
8.3.1.1.8 SKIN SMOOTHING
8.3.1.1.9 DENTISTRY
8.3.1.1.10 AESTHETIC RESTORATION
8.3.1.1.11 SCAR TREATMENT
8.3.1.1.12 CHIN AUGMENTATION
8.3.1.1.13 LIPOATROPHY TREATMENT
8.3.1.1.14 EARLOBE REJUVENATION
8.3.1.1.15 OTHERS
8.3.2 CALCIUM HYDROXYLAPATITE
8.3.2.1 BY APPLICATION
8.3.2.1.1 FACE LIFT
8.3.2.1.2 RHINOPLASTY
8.3.2.1.3 RECONSTRUCTIVE SURGERY
8.3.2.1.4 FACIAL LINE CORRECTION
8.3.2.1.5 LIP ENHANCEMENT
8.3.2.1.6 SAGGING SKIN
8.3.2.1.7 CHEEK DEPRESSION
8.3.2.1.8 SKIN SMOOTHING
8.3.2.1.9 DENTISTRY
8.3.2.1.10 AESTHETIC RESTORATION
8.3.2.1.11 SCAR TREATMENT
8.3.2.1.12 CHIN AUGMENTATION
8.3.2.1.13 LIPOATROPHY TREATMENT
8.3.2.1.14 EARLOBE REJUVENATION
8.3.2.1.15 OTHERS
8.3.3 POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA)
8.3.3.1 BY APPLICATION
8.3.3.1.1 FACE LIFT
8.3.3.1.2 RHINOPLASTY
8.3.3.1.3 RECONSTRUCTIVE SURGERY
8.3.3.1.4 FACIAL LINE CORRECTION
8.3.3.1.5 LIP ENHANCEMENT
8.3.3.1.6 SAGGING SKIN
8.3.3.1.7 CHEEK DEPRESSION
8.3.3.1.8 SKIN SMOOTHING
8.3.3.1.9 DENTISTRY
8.3.3.1.10 AESTHETIC RESTORATION
8.3.3.1.11 SCAR TREATMENT
8.3.3.1.12 CHIN AUGMENTATION
8.3.3.1.13 LIPOATROPHY TREATMENT
8.3.3.1.14 EARLOBE REJUVENATION
8.3.3.1.15 OTHERS
8.3.4 POLYALKYLIMIDE
8.3.4.1 BY APPLICATION
8.3.4.1.1 FACE LIFT
8.3.4.1.2 RHINOPLASTY
8.3.4.1.3 RECONSTRUCTIVE SURGERY
8.3.4.1.4 FACIAL LINE CORRECTION
8.3.4.1.5 LIP ENHANCEMENT
8.3.4.1.6 SAGGING SKIN
8.3.4.1.7 CHEEK DEPRESSION
8.3.4.1.8 SKIN SMOOTHING
8.3.4.1.9 DENTISTRY
8.3.4.1.10 AESTHETIC RESTORATION
8.3.4.1.11 SCAR TREATMENT
8.3.4.1.12 CHIN AUGMENTATION
8.3.4.1.13 LIPOATROPHY TREATMENT
8.3.4.1.14 EARLOBE REJUVENATION
8.3.4.1.15 OTHERS
8.3.5 OTHERS
9 NORTH AMERICA DERMAL FILLERS MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 FACE LIFT
9.2.1 DEEP PLANE/SMAS FACE
9.2.2 MINI FACE LIFT
9.2.3 MID-FACE LIFT
9.2.4 JAW LINE
9.2.5 CUTANEOUS LIFT
9.2.6 TEMPORAL OR BROW LIFT
9.2.7 LIQUID FACE LIFT
9.2.8 OTHERS
9.2.8.1 JUVEDERM
9.2.8.2 RESTYLANE
9.2.8.3 SCULPTRA
9.2.8.4 DYSPORT
9.2.8.5 OTHERS
9.3 RHINOPLASTY
9.3.1 JUVEDERM
9.3.1.1 JUVEDERM XC
9.3.1.2 JUVEDERM ULTRA XC
9.3.1.3 JUVEDERM VOLUMA
9.3.1.4 JUVEDERM VOLBELLA
9.3.1.5 JUVEDERM VOLLURE XC
9.3.2 RESTYLANE
9.3.2.1 RESTYLANE SILK
9.3.2.2 RESTYLANE LYFT
9.3.2.3 RESTYLANE REFYNE
9.3.2.4 RESTYLANE DEFYNE
9.3.2.5 RESTYLANE-L
9.3.3 OTHERS
9.4 RECONSTRUCTIVE SURGERY
9.4.1 JUVEDERM
9.4.2 RESTYLANE
9.4.3 OTHERS
9.5 FACIAL LINE CORRECTION
9.5.1 DYNAMIC WRINKLES
9.5.2 STATIC WRINKLES
9.5.3 WRINKLE FOLDS
9.5.3.1 FOREHEAD LINES
9.5.3.2 WORRY LINES
9.5.3.3 BUNNIES
9.5.3.4 CROW’S FEET
9.5.3.5 LAUGH LINES
9.5.3.6 LIP LINES
9.5.3.7 MARIONETTE LINES
9.5.3.8 OTHERS
9.5.3.8.1 JUVEDERM
9.5.3.8.2 RESTYLANE
9.5.3.8.3 RADIESSE
9.5.3.8.4 BELOTERO
9.5.3.8.5 OTHERS
9.6 LIP ENHANCEMENT
9.6.1 JUVEDERM
9.6.1.1 JUVÉDERM XC
9.6.1.2 JUVÉDERM ULTRA XC
9.6.1.3 JUVÉDERM VOLUMA
9.6.1.4 JUVÉDERM VOLBELLA
9.6.1.5 JUVÉDERM VOLLURE XC
9.6.2 RESTYLANE
9.6.2.1 RESTYLANE SILK
9.6.2.2 RESTYLANE LYFT
9.6.2.3 RESTYLANE REFYNE
9.6.2.4 RESTYLANE DEFYNE
9.6.2.5 RESTYLANE-L
9.6.3 BELOTERO BALANCE
9.6.4 REVANESSE VERSA
9.6.5 HYLAFORM
9.6.6 PREVELLE SILK
9.6.7 OTHERS
9.7 SAGGING SKIN
9.7.1 JUVEDERM
9.7.2 RESTYLANE
9.7.3 BELOTERO
9.7.4 OTHERS
9.8 CHEEK DEPRESSION
9.8.1 JUVEDERM VOLUMA
9.8.2 RESTYLANE-LYFT
9.8.3 SCULPTRA
9.8.4 RADIESSE
9.8.5 OTHERS
9.9 SKIN SMOOTHENING
9.9.1 RESTYLANE
9.9.2 BELOTERO
9.9.3 BELLAFIL
9.9.4 OTHERS
9.1 DENTISTRY
9.10.1 JUVEDERM
9.10.2 RESTYLANE
9.10.3 RADIESSE
9.10.4 OTHERS
9.11 AESTHETIC RESTORATION
9.11.1 JUVEDERM
9.11.1.1 JUVEDERM ULTRA XC
9.11.1.2 JUVEDERM VOLLURE XC
9.11.1.3 JUVEDERM VOLBELLA XC
9.11.2 RESTYLANE
9.11.2.1 RESTYLANE-L
9.11.2.2 RESTYLANE SILK
9.11.2.3 RESTYLANE REFYNE AND DEFYNE
9.11.2.4 RESTYLANE LYFT
9.12 REVANESSE VERSA
9.13 SCULPTRA
9.14 RHA
9.14.1 RHA 2
9.14.2 RHA 3
9.14.3 RHA 4
9.15 BELLAFIL
9.16 BELOTERO BALANCE
9.17 OTHERS
9.18 LIP PLUM
9.18.1 RESTYLANE
9.18.2 BELOTERO
9.18.3 OTHERS
9.19 SCAR TREATMENT
9.19.1 JUVEDERM
9.19.2 RESTYLANE
9.19.3 RADIESSE
9.19.4 BELOTERO
9.19.5 PERLANE
9.19.6 OTHERS
9.19.6.1 KELOID SCARS
9.19.6.2 CONTRACTURE SCARS
9.19.6.3 HYPERTROPHIC SCARS
9.19.6.4 ACNE SCARS
9.19.6.5 OTHERS
9.2 CHIN AUGMENTATION
9.20.1 JUVEDERM VOLUMA XC
9.20.2 RESTYLANE
9.20.3 OTHERS
9.21 LIPOATROPHY TREATMENT
9.21.1 SCULPTRA
9.21.2 OTHERS
9.22 EARLOBE REJUVENATION
9.22.1 JUVEDERM
9.22.2 RESTYLANE
9.22.3 SCULPTRA
9.22.4 BELOTERO
9.22.5 ELLANSE
9.22.6 OTHERS
9.23 OTHERS
10 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 BRANDED
10.2.1 JUVEDERM
10.2.1.1 JUVÉDERM XC
10.2.1.2 JUVÉDERM ULTRA XC
10.2.1.3 JUVÉDERM ULTRA PLUS XC
10.2.1.4 JUVÉDERM VOLBELLA
10.2.1.5 JUVÉDERM VOLUMA
10.2.1.6 JUVÉDERM VOLLURE
10.2.2 RESTYLANE
10.2.2.1 RESTYLANE-L
10.2.2.2 RESTYLANE REFYNE
10.2.2.3 RESTYLANE DEFYNE
10.2.2.4 RESTYLANE LYFT
10.2.2.5 RESTYLANE SILK
10.2.2.6 RESTYLANE KYSSE
10.2.2.7 RESTYLANE CONTOUR
10.2.3 RADIESSE
10.2.4 SCULPTRA
10.2.5 ELLANSE
10.2.5.1 ELLANSE-S
10.2.5.2 ELLANSE-M
10.2.5.3 ELLANSE-L
10.2.5.4 ELLANSE-E
10.2.6 BELLAFILL
10.2.7 AQUAMID
10.2.8 OTHERS
10.3 GENERIC
11 NORTH AMERICA DERMAL FILLERS MARKET, BY END USER
11.1 OVERVIEW
11.2 DERMATOLOGY CLINICS
11.3 HOSPITALS
11.4 AMBULATORY SURGICAL CENTERS
11.5 ACADEMIC RESEARCH INSTITUTES
11.6 OTHERS
12 NORTH AMERICA DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 DRUG STORES
12.4 RETAIL PHARMACY
12.5 ONLINE PHARMACY
12.6 OTHERS
13 NORTH AMERICA DERMAL FILLERS MARKET, BY GEOGRAPHY
13.1 NORTH AMERICA
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA DERMA FILLERS MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 ALLERGAN (A SUBSIDIARY OF ABBVIE INC.)
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 PRODUCT PORTFOLIO
16.1.5 RECENT DEVELOPMENTS
16.2 GALDERMA LABORATORIES, L.P
16.2.1 COMPANY SNAPSHOT
16.2.2 COMPANY SHARE ANALYSIS
16.2.3 PRODUCT PORTFOLIO
16.2.4 RECENT DEVELOPMENTS
16.3 MERZ NORTH AMERICA, INC (A SUBSIDIARY OF MERZ PHARMA)
16.3.1 COMPANY SNAPSHOT
16.3.2 COMPANY SHARE ANALYSIS
16.3.3 PRODUCT PORTFOLIO
16.3.4 RECENT DEVELOPMENTS
16.4 SINCLAIR PHARMA (A SUBSIDIARY OF HUADONG MEDICINE)
16.4.1 COMPANY SNAPSHOT
16.4.2 COMPANY SHARE ANALYSIS
16.4.3 PRODUCT PORTFOLIO
16.4.4 RECENT DEVELOPMENT
16.5 REVANCE THERAPEUTICS, INC.
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 PRODUCT PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 AMALIAN
16.6.1 COMPANY SNAPSHOT
16.6.2 PRODUCT PORTFOLIO
16.6.3 RECENT DEVELOPMENTS
16.7 ANIKA THERAPEUTICS, INC.
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 PRODUCT PORTFOLIO
16.7.4 RECENT DEVELOPMENTS
16.8 BIOPLUS CO., LTD.
16.8.1 COMPANY SNAPSHOT
16.8.2 PRODUCT PORTFOLIO
16.8.3 RECENT DEVELOPMENTS
16.9 BIOXIS PHARMACEUTICALS
16.9.1 COMPANY SNAPSHOT
16.9.2 PRODUCT PORTFOLIO
16.9.3 RECENT DEVELOPMENTS
16.1 CONTURA INTERNATIONAL LTD.
16.10.1 COMPANY SNAPSHOT
16.10.2 PRODUCT PORTFOLIO
16.10.3 RECENT DEVELOPMENTS
16.11 CROMA-PHARMA GMBH
16.11.1 COMPANY SNAPSHOT
16.11.2 PRODUCT PORTFOLIO
16.11.3 RECENT DEVELOPMENT
16.12 DSM
16.12.1 COMPANY SNAPSHOT
16.12.2 PRODUCT PORTFOLIO
16.12.3 RECENT DEVELOPMENT
16.13 FILLMED
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 GIVAUDAN
16.14.1 COMPANY SNAPSHOT
16.14.2 RECENT FINANCIALS
16.14.3 PRODUCT PORTFOLIO
16.14.4 RECENT DEVELOPMENT
16.15 HUMEDIX (A SUBSIDIARY OF HUONS NORTH AMERICA)
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 PRODUCT PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 IBSA FARMACEUTICI ITALIA SRL (A SUBSIDIARY OF IBSA INSTITUT BIOCHIMIQUE SA)
16.16.1 COMPANY SNAPSHOT
16.16.2 PRODUCT PORTFOLIO
16.16.3 RECENT DEVELOPMENT
16.17 IPSEN PHARMA.
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 PRODUCT PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 MEDYTROX
16.18.1 COMPANY SNAPSHOT
16.18.2 PRODUCT PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
16.19 MESOESTETIC
16.19.1 COMPANY SNAPSHOT
16.19.2 PRODUCT PORTFOLIO
16.19.3 RECENT DEVELOPMENTS
16.2 PROLLENIUM MEDICAL TECHNOLOGIES
16.20.1 COMPANY SNAPSHOT
16.20.2 PRODUCT PORTFOLIO
16.20.3 RECENT DEVELOPMENT
16.21 SHANGHAI REYOUNGEL MEDICAL TECHNOLOGY COMPANY LIMITED
16.21.1 COMPANY SNAPSHOT
16.21.2 PRODUCT PORTFOLIO
16.21.3 RECENT DEVELOPMENTS
16.22 SOSUM NORTH AMERICA
16.22.1 COMPANY SNAPSHOT
16.22.2 PRODUCT PORTFOLIO
16.22.3 RECENT DEVELOPMENT
16.23 SUNEVA MEDICAL
16.23.1 COMPANY SNAPSHOT
16.23.2 PRODUCT PORTFOLIO
16.23.3 RECENT DEVELOPMENT
16.24 TEOXANE SA
16.24.1 COMPANY SNAPSHOT
16.24.2 PRODUCT PORTFOLIO
16.24.3 RECENT DEVELOPMENTS
16.25 ZHEJIANG JINGJIA MEDICAL TECHNOLOGY CO., LTD
16.25.1 COMPANY SNAPSHOT
16.25.2 PRODUCT PORTFOLIO
16.25.3 RECENT DEVELOPMENT
16.26 ZIMMER AESTHETICS
16.26.1 COMPANY SNAPSHOT
16.26.2 PRODUCT PORTFOLIO
16.26.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
表格列表
TABLE 1 COST OF DERMAL FILLERS
TABLE 2 COST OF PROCEDURE
TABLE 3 ASAPS PROCEDURE FACTS
TABLE 4 COMPENSATION COST FOR DERMAL FILLERS
TABLE 5 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 7 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)
TABLE 9 NORTH AMERICA BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY PRODUCT TYPE, VOLUME, 2020-2029 (UNITS)
TABLE 10 NORTH AMERICA NON-BIODEGRADABLE DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 12 NORTH AMERICA NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 13 NORTH AMERICA NATURAL DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 14 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 15 NORTH AMERICA MONOPHASIC FILLERS IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 16 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 17 NORTH AMERICA HYALURONIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 18 NORTH AMERICA FAT IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 19 NORTH AMERICA COLLAGEN IN DERMAL FILLERS MARKET, BY APPLICATION, 2022-2029 (USD MILLION)
TABLE 20 NORTH AMERICA SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 21 NORTH AMERICA SYNTHETIC DERMAL FILLERS IN DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2020-2029 (USD MILLION)
TABLE 22 NORTH AMERICA POLY-L-LACTIC ACID IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 23 NORTH AMERICA CALCIUM HYDROXYLAPATITE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 24 NORTH AMERICA POLYMETHYL-METHACRYLATE MICROSPHERES (PMMA) IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 25 NORTH AMERICA POLYALKYLIMIDE IN DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 26 NORTH AMERICA DERMAL FILLERS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)
TABLE 27 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 29 NORTH AMERICA FACE LIFT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 30 NORTH AMERICA RHINOPLASTY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 NORTH AMERICA RHINOPLASTY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 32 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 33 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 34 NORTH AMERICA RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 35 NORTH AMERICA RECONSTRUCTIVE SURGERY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 36 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 37 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 38 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY TYPE, 2020- 2029 (USD MILLION)
TABLE 39 NORTH AMERICA FACIAL LINE CORRECTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 40 NORTH AMERICA LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 41 NORTH AMERICA LIP ENHANCEMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 42 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 43 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 44 NORTH AMERICA SAGGING SKIN IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 45 NORTH AMERICA SAGGING SKIN IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 46 NORTH AMERICA CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 47 NORTH AMERICA CHEEK DEPRESSION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 48 NORTH AMERICA SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 49 NORTH AMERICA SKIN SMOOTHENING IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 50 NORTH AMERICA DENTISTRY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 51 NORTH AMERICA DENTISTRY IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 52 NORTH AMERICA AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 53 NORTH AMERICA AESTHETIC RESTORATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 54 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 55 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 56 NORTH AMERICA RHA IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 57 NORTH AMERICA LIP PLUM IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 58 NORTH AMERICA LIP PLUM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 59 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 60 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 61 NORTH AMERICA SCAR TREATMENT IN DERMAL FILLERS MARKET, BY TYPE, 2020-2029 (USD MILLION)
TABLE 62 NORTH AMERICA CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 63 NORTH AMERICA CHIN AUGMENTATION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 64 NORTH AMERICA LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 65 NORTH AMERICA LIPOATROPHY TREATMENT IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 66 NORTH AMERICA EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 67 NORTH AMERICA EARLOBE REJUVENTION IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 68 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 69 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 70 NORTH AMERICA BRANDED IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 71 NORTH AMERICA BRANDED IN DERMAL FILLERS MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 72 NORTH AMERICA JUVEDERM IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 73 NORTH AMERICA RESTYLANE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 74 NORTH AMERICA ELLANSE IN DERMAL FILLERS MARKET, BY BRAND, 2020-2029 (USD MILLION)
TABLE 75 NORTH AMERICA GENERIC IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 76 NORTH AMERICA DERMAL FILLERS MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 77 NORTH AMERICA DERMATOLOGY CLINICS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 78 NORTH AMERICA HOSPITALS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 79 NORTH AMERICA AMBULATORY SURGICAL CENTERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 80 NORTH AMERICA ACADEMIC RESEARCH INSTITUTES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 81 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 82 NORTH AMERICA DERMAL FILLERS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 83 NORTH AMERICA DIRECT TENDER IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 84 NORTH AMERICA DRUG STORES IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 85 NORTH AMERICA RETAIL PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 86 NORTH AMERICA ONLINE PHARMACY IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 87 NORTH AMERICA OTHERS IN DERMAL FILLERS MARKET, BY REGION, 2020-2029 (USD MILLION)
图片列表
FIGURE 1 NORTH AMERICA DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA DERMAL FILLERS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA DERMAL FILLERS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA DERMAL FILLERS MARKET : NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA DERMAL FILLERS MARKET : COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA DERMAL FILLERS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA DERMAL FILLERS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA DERMAL FILLERS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 NORTH AMERICA DERMAL FILLERS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA DERMAL FILLERS MARKET: SEGMENTATION
FIGURE 11 RISING DEMAND FOR ANTI-AGING DRUGS, AND GROWING POPULARITY OF NON-SURGICAL OR MINIMALLY INVASIVE AESTHETICS PROCEDURES ARE EXPECTED TO DRIVE THE NORTH AMERICA DERMAL FILLERS MARKET IN THE FORECAST PERIOD 2022 TO 2029
FIGURE 12 BIODEGRADABLE DERMAL FILLER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA DERMAL FILLERS MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA DERMAL FILLERS MARKET
FIGURE 14 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2021
FIGURE 15 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, 2022-2029 (USD MILLION)
FIGURE 16 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, CAGR (2022-2029)
FIGURE 17 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE, LIFELINE CURVE
FIGURE 18 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, 2021
FIGURE 19 NORTH AMERICA DERMAL FILLERS MARKET, BY MATERIAL TYPE, 2022-2029 (USD MILLION)
FIGURE 20 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, CAGR (2022-2029)
FIGURE 21 NORTH AMERICA DERMAL FILLERS MARKET: BY MATERIAL TYPE, LIFELINE CURVE
FIGURE 22 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, 2021
FIGURE 23 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, 2022-2029 (USD MILLION)
FIGURE 24 NORTH AMERICA DERMAL FILLERS MARKET : BY APPLICATION, CAGR (2022-2029)
FIGURE 25 NORTH AMERICA DERMAL FILLERS MARKET: BY APPLICATION, LIFELINE CURVE
FIGURE 26 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, 2021
FIGURE 27 NORTH AMERICA DERMAL FILLERS MARKET, BY DRUG TYPE, 2022-2029 (USD MILLION)
FIGURE 28 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 29 NORTH AMERICA DERMAL FILLERS MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 30 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, 2021
FIGURE 31 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, 2022-2029 (USD MILLION)
FIGURE 32 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, CAGR (2022-2029)
FIGURE 33 NORTH AMERICA DERMAL FILLERS MARKET: BY END USER, LIFELINE CURVE
FIGURE 34 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 35 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)
FIGURE 36 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 37 NORTH AMERICA DERMAL FILLERS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 38 NORTH AMERICA DERMAL FILLERS MARKET: SNAPSHOT (2021)
FIGURE 39 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2021)
FIGURE 40 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2022 & 2029)
FIGURE 41 NORTH AMERICA DERMAL FILLERS MARKET: BY COUNTRY (2021 & 2029)
FIGURE 42 NORTH AMERICA DERMAL FILLERS MARKET: BY PRODUCT TYPE (2022-2029)
FIGURE 43 NORTH AMERICA DERMA FILLERS MARKET: COMPANY SHARE 2021 (%)
研究方法
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
可定制
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
